Laboratorios Farmaceuticos Rovi (STU:41L) EBIT per Share : €5.29 (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi EBIT per Share?

Laboratorios Farmaceuticos Rovi's EBIT per Share for the three months ended in Dec. 2024 was €2.41. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €5.29.

During the past 12 months, the average EBIT per Share Growth Rate of Laboratorios Farmaceuticos Rovi was -15.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 2.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was 37.50% per year. During the past 10 years, the average EBIT per Share Growth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's EBIT per Share or its related term are showing as below:

STU:41L' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -16.8 Med: 7.45 Max: 126.3
Current: 2.3

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 126.30% per year. The lowest was -16.80% per year. And the median was 7.45% per year.

STU:41L's 3-Year EBIT Growth Rate is ranked worse than
59.59% of 824 companies
in the Drug Manufacturers industry
Industry Median: 8.3 vs STU:41L: 2.30

Laboratorios Farmaceuticos Rovi's EBIT for the three months ended in Dec. 2024 was €123.3 Mil.

Laboratorios Farmaceuticos Rovi EBIT per Share Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi EBIT per Share Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

1.33

3.31

4.84

4.16

3.51

Laboratorios Farmaceuticos Rovi Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															2.56	0.38	0.73	1.77	2.41

Laboratorios Farmaceuticos Rovi EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Laboratorios Farmaceuticos Rovi's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	179.678	/	51.210
=	3.51

Laboratorios Farmaceuticos Rovi's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	123.328	/	51.125
=	2.41

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.29

Laboratorios Farmaceuticos Rovi (STU:41L) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Laboratorios Farmaceuticos Rovi EBIT per Share Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Laboratorios Farmaceuticos Rovi SA (STU:41L) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 0ILL:UK ROVI:Spain 41L:Germany ROVI:Austria

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi Headlines

No Headlines